Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41003 phase II trial in superficial infected eczema
2009-011931-11Phase 2Completed
- Sponsor
- Almirall
- Start
- Aug 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing LAS41003 combination cream, Octenidine monotherapy cream and Prednicarbate monotherapy cream (3 arms). Primary endpoint: Primary efficacy variables. Started Aug 2009; status: completed.
02
Drugs
octenidineprednicarbateprednicarbate + octenidine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2009-011931-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011931-11.